<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="44691">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02524496</url>
  </required_header>
  <id_info>
    <org_study_id>0009012025</org_study_id>
    <nct_id>NCT02524496</nct_id>
  </id_info>
  <brief_title>Limited Access Protocol for the Use of Oral Cisapride</brief_title>
  <official_title>Limited Access, Open-label, Compassionate Use of Cisapride in the Treatment of Gastroparesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Due to the lack of other drugs to treat gastroparesis Janssen and FDA approved the
      compassionate use of cisapride to treat patients who had no other effective therapy. For
      this observational study, 3 patients who had already been prescribed cisapride by outside
      physicians, were followed to determine the effectiveness of cisapride on their gastric
      emtpying.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2001</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in gastric emptying via self-report</measure>
    <time_frame>ten years</time_frame>
    <description>Patients were asked at clinical appointments about problems and improvement with gastric emptying.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">3</enrollment>
  <condition>Gastroparesis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The subjects of the study were diagonosed with gastroparesis that was not being adequately
        treated.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of gastroparesis.

        Exclusion Criteria:

          -  No diagnosis of gastroparesis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>August 2015</verification_date>
  <lastchanged_date>August 13, 2015</lastchanged_date>
  <firstreceived_date>December 25, 2007</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Gastroparesis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cisapride</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
